Camp4 Therapeutics (CAMP) Change in Account Payables (2023 - 2026)
Camp4 Therapeutics' (CAMP) quarterly Change in Account Payables came in at $592000.0 in Q1 2026, up 238.29% year-on-year from $175000.0 in Q1 2025, and up 226.77% quarter-over-quarter from -$467000.0 in Q4 2025.
Camp4 Therapeutics (CAMP) Change in Account Payables (2023 - 2026) Analysis & Trends
Camp4 Therapeutics has disclosed Change in Account Payables across 4 years of filings, most recently posting $592000.0 for Q1 2026.
- Change in Account Payables for Q1 2026 came in at $592000.0, up 238.29% year-over-year; the trailing twelve-month figure through Mar 2026 was -$611000.0 (up 4.83% YoY), and the FY2025 annual result was -$1.0 million, down 711.9% from the prior year.
- Change in Account Payables came in at $592000.0 for Q1 2026 at Camp4 Therapeutics, up from -$467000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $1.1 million in Q3 2024 to a low of -$1.0 million in Q2 2024.
- The 4-year median for Change in Account Payables is -$170000.0 (2023), against an average of -$41800.0.
- Across the five-year window, Change in Account Payables tumbled 470.67% in 2024 and soared 238.29% in 2026, its largest moves.
- Camp4 Therapeutics' Change in Account Payables stood at -$150000.0 in 2023, then sank by 470.67% to -$856000.0 in 2024, then soared by 45.44% to -$467000.0 in 2025, then soared by 226.77% to $592000.0 in 2026.
- The last three Change in Account Payables figures came in at $592000.0 (Q1 2026), -$467000.0 (Q4 2025), and -$546000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -9.42 Mn |
| 10 | Camp4 Therapeutics | 245.02 Mn | 245.02 Mn | - | 592,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 592,000.00 |
| Mar 31, 2026 | 592,000.00 |
| Dec 31, 2025 | -467,000.00 |
| Dec 31, 2025 | -467,000.00 |
| Sep 30, 2025 | -546,000.00 |
| Sep 30, 2025 | -546,000.00 |
| Jun 30, 2025 | -190,000.00 |
| Jun 30, 2025 | -190,000.00 |
| Mar 31, 2025 | 175,000.00 |
| Mar 31, 2025 | 175,000.00 |
| Dec 31, 2024 | -856,000.00 |
| Dec 31, 2024 | -856,000.00 |
| Sep 30, 2024 | 1.08 Mn |
| Sep 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | -1.04 Mn |
| Jun 30, 2024 | -1.04 Mn |
| Mar 31, 2024 | 985,000.00 |
| Mar 31, 2024 | 985,000.00 |
| Dec 31, 2023 | -150,000.00 |
| Dec 31, 2023 | -150,000.00 |